US-based medical technology company Masimo has launched the Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring in India.
The products were launched at a roundtable involving CEOs of leading hospitals in Bangalore, India.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Masimo founder and CEO Joe Kiani said: “Masimo’s non-invasive patient monitoring technology innovations offer capabilities that have never been possible before.
“With a large population and a burgeoning demand for an improved quality of life including the safe, high-quality healthcare to which all are entitled India continues to be a focus market for Masimo.
“We will continue to invest in India and strive to make our technologies and products as accessible as possible, as evidenced by the new Rad-97 and Next Generation SedLine.”
Features like measure-through motion and low-perfusion SET pulse oximetry characterise Masimo’s Rad-97.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIt enables clinicians to reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and minimise rapid response activation and expenditure when used for continuous monitoring in post-surgical wards.
Rad-97 offers the upgradeable rainbow SET technology in a versatile, standalone monitor configuration. It allows monitoring of rainbow measurements in the form of total hemoglobin (SpHb) and PVi.
The rainbow can also measure methemoglobin (SpMet), acoustic respiration rate (RRa), carboxyhemoglobin (SpCO), oxygen reserve index (ORi), and oxygen content (SpOC).
Additionally, Rad-97 is fitted with an integrated camera for clinician tele-presence through Patient SafetyNet and a high-resolution 1080p HD colour display with user-friendly multi-touch navigation enabling clinicians to customise the device to suit their monitoring needs.
SedLine features four simultaneous electroencephalogram (EEG) leads for continuous assessment of both sides of the brain, as well as a Density Spectral Array (DSA), an easy-to-interpret, high-resolution display of bi-hemispheric activity.
The next generation SedLine has been designed to improve Masimo’s processed EEG parameter, the patient state index (PSI) and to avoid electromyographic (EMG) interference while improving performance in low-power EEG cases.
